J Pediatr by Shin, Mikyong et al.
Improved Survival Among Children with Spina Bifida in the 
United States
Mikyong Shin, DrPH1,2, James E. Kucik, MPH1, Csaba Siffel, MD, PhD1, Chengxing Lu, 
PhD1,3, Gary M. Shaw, DrPH4, Mark A. Canfield, PhD5, and Adolfo Correa, MD, PhD1,6
1Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and, 
Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
2RTI International, Atlanta, GA
3Oak Ridge Institute for Science and Education, Oak Ridge, TN
4Stanford University School of Medicine, Stanford, CA
5Texas Department of State Health Services, Austin, TX
6Department of Medicine, University of Mississippi Medical Center, Jackson, MS
Abstract
Objective—To evaluate trends in survival among children with spina bifida by race/ethnicity and 
possible prognostic factors in 10 regions of the United States.
Study design—A retrospective cohort study was conducted of 5165 infants with spina bifida 
born during 1979-2003, identified by 10 birth defects registries in the United States. Survival 
probabilities and adjusted hazard ratios were estimated for race/ethnicity and other characteristics 
using the Cox proportional hazard model.
Results—During the study period, the 1-year survival probability among infants with spina 
bifida showed improvements for whites (from 88% to 96%), blacks (from 79% to 88%), and 
Hispanics (from 88% to 93%). The impact of race/ethnicity on survival varied by birth weight, 
which was the strongest predictor of survival through age 8. There was little racial/ethnic variation 
in survival among children born of very low birth weight. Among children born of low birth 
weight, the increased risk of mortality to Hispanics was approximately 4-6 times that of whites. 
The black-white disparity was greatest among children born of normal birth weight. Congenital 
heart defects did not affect the risk of mortality among very low birth weight children but 
increased the risk of mortality 4-fold among children born of normal birth weight.
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Conclusions—The survival of infants born with spina bifida has improved; however, 
improvements in survival varied by race/ethnicity, and blacks and Hispanics continued to have 
poorer survival than whites in the most recent birth cohort from 1998-2002. Further studies are 
warranted to elucidate possible reasons for the observed differences in survival.
Spina bifida, the most common type of neural tube defect, is defined as a protrusion of the 
spinal cord and/or meninges through a defect in the vertebral arches.1-5 Although the birth 
prevalence of spina bifida significantly decreased after the introduction of mandatory 
fortification of enriched grain products with folic acid in the United States,6-10 the 
population burden of spina bifida continues both in birth prevalence and in disparities in 
long-term outcomes. A birth prevalence estimate of spina bifida from 11 population-based 
surveillance programs in the United States was reported as 3.7 per 10 000 live births 
(1999-2001).11 A 1-year survival estimate of 92.1% was reported by a study of 16 US birth 
defect monitoring programs for 1995-2001.12 A recent long-term follow-up study of 
children with spina bifida in the United Kingdom estimated the survival experience at 1, 5, 
and 20 years of age to be 71%, 69%, and 66%, respectively.13 Furthermore, another United 
Kingdom study found that the 5-year survival varied considerably by severity of the lesion, 
with a 40% lower survival among children with open lesions compared with those with 
closed lesions.14
Of particular concern is an observation of a lower survival experience among non-Hispanic 
black children born with spina bifida than among non-Hispanic white children born with 
spina bifida in the metropolitan Atlanta area.15 Although the reasons for this racial/ethnic 
disparity in survival for children with spina bifida are unknown, this observation raises 
questions as to whether this finding might be evident in a national sample of children with 
spina bifida. As timely access to quality health care is important in reducing morbidity and 
mortality associated with spina bifida, it becomes important from a public health perspective 
to identify high-risk subpopulations of children with spina bifida, for whom targeted 
interventions may be made available to prevent complications and thereby improve their 
survival. In this study, we evaluated the long-term trend in survival among infants born with 
spina bifida by race/ethnicity and investigated maternal and infant characteristics associated 
with survival experience using data from 10 population-based surveillance programs in the 
United States. We also examined variations in survival probability by race/ethnicity after 
adjusting for other factors.
Methods
A total of 5165 infants born with spina bifida were identified through 10 population-based 
birth defect monitoring programs located in the following regions: Arkansas (AR) birth 
cohort from 1993 to 2002; Georgia (GA) births in 5 central Atlanta counties from 1979 to 
2003; California (CA) births in 11 counties from 1983 to 2002; Colorado (CO) births from 
1989 to 2003; Iowa (IA) births from 1983 to 2003; North Carolina (NC) births from 1989 to 
2003; New York (NY) births (excluding New York City) from 1983 to 2003; Oklahoma 
(OK) births from 1994 to 2003; Texas (TX) births from 1996 to 2003; and Utah births (UT) 
from 1994-2003 (Table I; available at www.jpeds.com). We included liveborn infants with 
spina bifida (International Classification of Diseases, Ninth Revision, Clinical Modification 
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[ICD-9-CM] codes 741.0 and 741.9) but excluded those with anencephaly (ICD-9-CM code 
740.0), as well as those coded as possible/probable spina bifida cases based on the British 
Paediatric Association (BPA) codes modified by the Centers for Disease Control and 
Prevention. A previous report estimated the prevalence among older ages using a subgroup 
(n = 3390) of this study population that included those alive in 2002.16
Deaths among affected infants were ascertained by linking state vital records, medical 
records, and the National Death Index, and deaths were ascertained only from medical 
records and the National Death Index for 1998 data in CA. Patients without death records 
were considered alive at the end of the state’s follow-up period and treated as censored in 
the survival analysis. Details about the regional surveillance programs have been 
published.17
Long-Term Trends in Survival Probability of Infants with Spina Bifida
To examine the temporal trends in survival probabilities over the 20-year study period, we 
compared survival probabilities to 1 year for each birth cohort (1983-1987, 1988-1992, 
1993-1997, 1998-2003) overall and by race/ethnicity (non-Hispanic whites [referred to as 
whites], non-Hispanic blacks [referred to as blacks], Hispanics, and other). Trends in 1-year 
mortality were examined using data from 4 regions (GA, CA, IA, and NY) with at least 20 
years of long-term follow-up. We calculated P values to show the significant increasing 
trends in 1-year survival over 4 birth cohorts.
Prognostic Factors of Survival Probabilities
Maternal and infant characteristics were obtained from medical records and birth 
certificates. Maternal characteristics considered were maternal race/ethnicity (white, black, 
Hispanic, other) and maternal age (<35 years vs ≥35 years). Infant characteristics included 
sex (male vs female), birth weight (<1500 g, 1500-2499 g, ≥2500 g), plurality (multiple vs 
singleton), presence of major heart defects (yes vs no), and spina bifida lesion level 
(cervicothoracic vs lumbosacral). We classified infants as having a major congenital heart 
defect using an algorithm we developed based on ICD-9/BPA classification codes. With the 
exception of NC, where only 4-digit ICD-9 codes were used, all regions used the most 
detailed ICD-9-CM or modified BPA codes. Codes for normal physiological findings in 
newborns or premature infants (eg, patent foramen ovale, patent ductus arteriosus), minor 
conditions such as tricuspid insufficiency, or unconfirmed cardiac defects were not 
considered structural heart defects. For heart defect codes that lacked specificity or may 
have included both major and minor cardiac defects, an expert in pediatric cardiology 
assisted in the decision for inclusion in the major heart defect group. The distribution of 
each characteristic by region is presented in Table II (available at www.jpeds.com).
One-Year Survival Probabilities for Infants with Spina Bifida by Selected Characteristics
For children born during 1997 to 2003 (n = 2259), Kaplan-Meier 1-year survival 
probabilities were estimated and Greenwood’s method was used to calculate the variance 
and their 95% CIs.18 The log-rank test was used to determine whether 1-year survival 
functions were significantly different among different levels of maternal and infant 
characteristics.19 Adjusted hazard ratios were estimated using Cox proportional hazard 
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models, stratified by survival time (1 month, 1 year, 5 years, and 8 years, which is the 
maximum years of follow-up for the limited cohort).20 The assumption of proportionality 
was checked by plotting the estimated log-cumulative hazard versus the log of survival time 
to examine if they were parallel for different categories of the risk factors. Possible time-
dependent trends were also tested to check the assumption of proportionality. Possible 
interactions between the significant unadjusted risk factors were also examined. 
Computations were performed using SAS-PC (version 9.13; SAS Institute, Cary, North 
Carolina).
Results
The cohorts of children with spina bifida from the 10 regions varied in size, birth years, 
follow-up years, and length of follow-up, with some data available representing birth years 
from 1979 to 2003 (Table I). The maternal and child characteristics of each regional cohort 
are shown in Table II. Although maternal white was the predominant racial/ethnic group for 
all regions combined, the relative proportions of blacks and Hispanics varied among regions. 
Infants of Hispanic mothers comprised >50% of the spina bifida cohorts in CA and TX, and 
infants of black mothers comprised >20% of the spina bifida cohorts in GA and NC. The 
proportion of mothers 35 years or older was similar across regions. For maternal education, 
there was a fair amount of variation in the proportion of children with spina bifida, with 
missing information for some regions (ie, GA and CA). There were no major regional 
differences in spina bifida cohorts with respect to sex, maternal age, or plurality. There was 
some variation in the proportion of children with spina bifida who also had congenital heart 
defects, ranging from 2.7% in GA to 12.7% in UT. However, this variation was not 
statistically significant. For lesion level, 41% of children with spina bifida had missing 
information.
The overall survival estimates for 1983-2003 to 1, 5, and 20 years were 90.8%, 88.7%, and 
85.2%, respectively, and differed by race/ethnicity (P = .002) (Figure 1). The overall 
survival improved among more recent birth cohorts (Figure 2; available at www.jpeds.com). 
In the 4 regions with at least 20 years of data (GA, CA, IA, NY, n = 2699), the 1-year 
survival probability during 1983-2002 showed an improving trend from 87.1% to 93.6% that 
was statistically significant (P = .0004) (Figure 3). This improving trend was evident for 
whites (from 87.9% to 95.9%) (P = .006) and Hispanics (from 88.3% to 92.6%) (P = .0556). 
The survival among blacks improved from 79.1% to 87.5%, a 10.6% increase, which was 
the largest increase among the racial/ethnic groups; however, the statistical test for trend was 
not significant (P = .4643) because of an unusually high spike in the survival probability for 
the second earliest birth cohort. Despite the sharp increase in survival, the survival 
probability for blacks in the most recent birth cohort remained lower than those for other 
groups.
Characteristics found to be significantly associated with decreased 1-year survival 
probability for children with spina bifida during 1997-2003 in the 10 US regions were 
maternal black race, multiple births, low birth weight, presence of major heart defects, and 
cervicothoracic lesions (Table III). Because of the high proportion of missing data for 
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maternal education and lesion level, these variables were not considered in subsequent 
analyses.
In multivariable models, an increased risk of mortality was evident for black and Hispanic 
children with spina bifida compared with white children with spina bifida from 1 month of 
age and extending to 5 and 8 years of age, after adjustment for other variables (Table IV). 
The estimated hazard for maternal race/ethnicity and the presence of a major heart defect 
differed significantly across levels of birth weight; therefore, hazard ratios are stratified by 
birth weight. Because no deaths occurred between the ages of 5 and 8 years, hazard ratios 
are presented for age 8 only. Maternal race/ethnicity was not associated with an increased 
hazard for death among children born of very low birth weight but was associated with an 
increased hazard among children born of low and normal birth weight. The presence of a 
major heart defect was associated with a decreased risk among children born of very low 
birth weight and showed the highest risk for death among children born of normal birth 
weight, for whom there was an approximately 4-fold increase in mortality risk. The 
improved survival for children born with spina bifida in the more recent birth cohort became 
more apparent in children born of low and normal birth weight.
Discussion
We found that the 1-year survival probability has improved over time for all children with 
spina bifida, but the magnitude of improvements varied by race/ethnicity. The factors most 
associated with a lower survival probability among children with spina bifida were low birth 
weight and the presence of major heart defects. We also found that children with spina 
bifida born to nonwhite mothers had a lower probability of survival compared with children 
born to white mothers, but this disparity was not present among children born of very low 
birth weight.
Although there were regional variations in survival in our study, the pooled survival 
probability at 1 year of age (92.8% in 10 US regions during 1997-2003) was comparable 
with those in previous studies. In particular, a study reported a 1-year survival probability 
for children with spina bifida of 92.1% during 1995-2001.12 Our findings and those of 
others highlight improved survival for children with spina bifida in recent decades. 
Advanced medical and surgical management including elective repair of spina bifida lesions 
in utero has been suggested as a contributing factor in the improvement of survival 
probability among children with spina bifida.1 It has also been suggested that folic acid 
fortification might have improved survival by reducing the risk of severe types of spina 
bifida.1,12,21-23 Our data suggest that survival did improve among cohorts born after 
fortification of folic acid (Figure 2), but it is unclear whether the improvement was caused in 
part by folic acid fortification or if the improvement was an extension of a previous trend 
toward improved survival. Such a trend may have occurred as a result of advances in the 
clinical treatment and management of congenital heart defects and conditions related to 
being born of low birth weight.
Our findings also found racial/ethnic disparities in the improvement of survival probabilities 
for children with spina bifida during 1983-2002. Survival among blacks and Hispanics with 
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spina bifida improved over time but was consistently lower compared with that of whites. In 
a previous study in Atlanta, the survival probability during 1979-1994 was reported to be 
67.1% for blacks and 82.8% for whites,15 although this difference was not statistically 
significant after adjusting for other factors. In our study, poorer survival among blacks 
compared with whites was statistically significant only for 1-year mortality in infants of 
normal birth weight, although the data suggest an increased risk of mortality at all ages for 
each birth weight group except for those born of very low birth weight. Similarly, Hispanics 
born of very low birth weight had no excess risk of mortality, but Hispanic infants of low 
birth weight had an increased risk up to 6 times that of whites. Future studies should 
examine possible modifiable factors influencing race/ethnic disparities in survival, including 
barriers to access to health care.
Birth weight was the strongest predictor of infant mortality even after adjusting for race, and 
it continued to be significantly associated with poor survival through age 8. In our study, 
17% of infants with spina bifida were born with very low or low birth weight compared with 
8% in the general population.24 Infants born of low birth weight in our study were 4 times 
more likely to die in infancy compared with very low or low birth weight infants in the 
general US population.25 The vulnerability of this group should prompt increased clinical 
vigilance, particularly during infancy, to reduce the mortality risk.
In our analysis, the presence of major heart defects had a significant impact on the survival 
of children with spina bifida. We did not have information on treatment for congenital heart 
defects or on the presence of other major noncardiac defects, so it was not possible for us to 
examine the impact of clinical characteristics and management on survival. Further studies 
are warranted to examine how these factors may impact the survival of children with spina 
bifida.
In the univariate analyses, there was some suggestion that the higher cervicothoracic lesions 
were associated with a lower survival than for lumbosacral, a finding consistent with a 
previous study.12 However, for nearly one-half of the children with spina bifida, information 
on the level of the lesion was not available. Because the level of the lesion could potentially 
be related to both survival and the long-term quality of life of affected children, future 
studies of survival could fill important knowledge gaps for clinical decision making by 
examining detailed survival probabilities by lesion level.
Trends in the improving survival may be attributable to improved prenatal screening and 
differential decision making following a prenatal diagnosis.26,27 Parents may decide more 
often to terminate the pregnancy if their fetus has a more severe type of spina bifida or the 
fetus has other major associated defects. If true, this would result in a higher number of 
infants with less severe type of spina bifida, which in turn could impact survival estimates. 
Future studies to evaluate the impact on survival should include an examination of the 
epidemiology of prenatally diagnosed cases and patterns of terminated pregnancies.
Our study examined racial/ethnic variations in survival using a large sample size from 10 
US population-based surveillance programs that encompassed a wide geographic and racial/
ethnic diversity. Ascertainment of vital status was done using comprehensive data sources to 
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minimize the underestimation of deaths among the study participants.28 One of the 
limitations of our study was the regional and periodic variation of maternal and infant 
characteristics and variations in the diagnostic coding by surveillance system. We also 
lacked information on any surgeries, care management, and barriers to access to health care 
to examine the prognostic impact of these factors on survival.
This study identified improvements in survival among children with spina bifida over the 
past 2 decades, noting that some racial/ethnic disparities in survival have decreased in recent 
years but still persist. Given the important attendant severity of conditions and chronic 
complications associated with spina bifida, the improved survival of children with spina 
bifida raises important challenges for health care providers responsible for providing 
prognostic information and advice to at-risk individuals, families, and communities.
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Kaplan-Meier survival curves for children born with spina bifida by race/ethnicity, 
1983-2003.
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Kaplan-Meier survival curves for children born with spina bifida by birth cohort, 
1983-2003.
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Trends in survival probability to 1 year by race/ethnicity (GA [5 metropolitan Atlanta 
counties], CA [11 counties], IA, NY [New York City excluded]: non-Hispanic white 1543, 
non-Hispanic black 205, Hispanic 951) and birth cohort in 4 regions during 1983-2002. P 
values for increasing trend based on an unadjusted proportional hazard model.
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Table I
Cohorts of children with spina bifida and 1-year survival probability from 10 US regions 
for various years from 1979-2003
Region Sample size Birth years Follow-up years Length of follow-up, 
y
Person-years Overall 1-year survival 
probability
AR 161 1993-2002 1993-2003 11 879 84.9
GA 332 1979-2003 1979-2004 26 4000 79.3
CA 1321 1983-2002 1983-2002 20 10 076 85.1
CO 233 1989-2003 1989-2004 16 1738 86.4
IA 361 1983-2003 1983-2004 22 3897 84.8
NC 684 1989-1993, 1995-2003 1989-2004 16 5031 86.5
NY 985 1983-2003 1983-2004 22 11 423 83.4
OK 207 1994-2003 1994-2004 11 1200 90.3
TX 747 1996-2003 1996-2004 9 3212 90.2
UT 134 1994-2003 1994-2004 11 719 87.7
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Table III
One-year survival probabilities for infant with spina bifida by selected maternal and 
infant characteristics in 10 US regions* during 1997-2003
Characteristics No. of births of infants with spina 
bifida
No. of deaths (%) Survival probabilities (%) with 95% 
CIs
Log-rank test, P
Total 2259 162 (7.2%) 92.8 (91.7-93.8)
Mother’s race/ethnicity, n
 White 1110 65 (5.9%) 94.1 (92.6-95.4)
.0103
‡
 Black 205 25 (12.2%) 87.8 (82.5-91.6)
 Hispanic 876 68 (7.8%) 92.2 (90.3-93.8)
 Other 64 4 (6.3%) 93.8 (84.2-97.6)
 Missing 4 0 (0%)
Maternal education, y
 ≥12 1474 98 (6.6%) 93.4 (92.0-94.5) .4083
 <12 709 54 (7.6%) 92.4 (90.2-94.1)
 Missing 76 10 (13.2%)
Maternal age, y
 <35 1978 141 (7.1%) 92.9 (91.6-93.9) .8347
 ≥35 280 21 (7.5%) 92.5 (88.7-95.0)
 Missing 1 0 (0%)
Plurality, n
 Singleton 2172 148 (6.8%) 93.1 (92.0-94.2) .0002‡
 Multiple 80 14 (17.5%) 82.5 (72.2-89.2)
 Missing 7 0 (0%)
Infant sex, n
 Male 1118 68 (6.1%) 91.8 (90.1-93.3) .0544
 Female 1140 93 (8.2%) 93.9 (92.3-95.2)
 Missing 1 1 (100%)
Birth weight, g
 <1500 99 59 (59.6%) 40.4 (30.7-49.9) <.0001‡
 1500-2499 311 36 (11.9%) 88.4 (84.3-91.5)
 ≥2500 1845 67 (3.6%) 96.4 (95.4-97.1)
 Missing 4 0 (0%)
Presence of major heart defects, n
 No 2082 130 (6.2%) 93.8 (92.6-94.7) <.0001‡
 Yes 177 32 (18.1%) 81.9 (75.4-86.8)
Lesion level†
 Cervicothoracic 203 33 (16.3%) 83.7 (77.9-88.2) <.0001‡
 Lumbosacral 1471 77 (5.2%) 94.8 (93.4-95.8)
 Missing 585 52 (8.9%)
*
AR, GA (5 metropolitan Atlanta counties), CA (11 counties), CO, IA, NC, NY (New York City excluded), OK, TX, and UT.
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†
The 25.9% of lesion level information is missing during this period.
‡
Statistical difference in survival probabilities.













Shin et al. Page 18
Table IV
The aHRs for race/ethnicity, presence of major heart defects, and low birth weight among 
children with spina bifida (N = 2259) in 10 US regions* by age at follow-up, 1997-2003
Very low birth weight (<1500 g) Low birth weight (1500-2499 g) Normal birth weight (≥2500 g)
Prognostic factor 1 mo old 1 y old 8 y old
† 1 mo old 1 y old 8 y old
† 1 mo 1 y old 8 y old
†
Race/ethnicity
 Blacks 1.1 (0.5-2.2) 1.1 (0.5-2.0) 1.0 (0.5-1.9) 1.5 (0.3-7.8) 1.4 (0.4-5.4) 2.0 (0.7-5.8) 1.8 (0.5-6.5) 2.1 (1.0-4.5) 1.9 (1.0-3.7)
 Hispanics 1.1 (0.6-2.1) 1.0 (0.5-1.9) 0.9 (0.5-1.8) 6.0 (2.3-16.0) 4.2 (1.9-9.4) 3.7 (1.8-7.8) 1.1 (0.5-2.7) 1.2 (0.7-2.0) 1.3 (0.8-1.9)
Presence of major
 heart defects
0.5 (0.2-1.4) 0.7 (0.3-1.5) 0.8 (.4-1.6) 1.3 (0.5-3.3) 2.1 (1.0-4.5) 2.6 (1.3-5.0) 3.9 (1.5-10.5) 4.6 (2.6-8.0) 3.6 (2.1-6.1)
Birth cohort 1.1 (0.6-1.9) 0.9 (0.5-1.6) 1.0 (0.6-1.6) 0.5 (0.3-1.1) 0.6 (0.3-1.2) 0.6 (0.3-1.1) 0.9 (0.4-2.0) 0.8 (0.5-1.2) 0.7 (0.5-1.1)
aHR, Adjusted hazard ratio.
Hazard ratios for blacks, Hispanics, and other; whites used as a reference group.
*
AR, GA (5 metropolitan Atlanta counties), CA (11 counties), CO, IA, NC, NY (New York City excluded), OK, TX, and UT.
†
No deaths occurred between ages 5 and 8 y, so the aHR at 5 years of age are identical to those at age 8 y.
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